Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse ...

Nvidia's positions in these companies were relatively small at the end of the third quarter of 2025, but the chipmaker has spent recent years building a portfolio of AI‑related investments across ...

Recursion Pharmaceuticals reports fourth-quarter and full-year 2025 results Wednesday before the market opens, with investors scrutinizing whether the AI-driven biotech can translate its massive data ...

As the new academic year begins, Snapchat is rolling out the next iteration of its integrated ‘Say it in a Snap’ campaign, positioning the platform as the digital equivalent of the university quad, ...

Delawareans may have to break out their ice scrapers and snow brushes next winter, or face a fine. A Senate bill introduced Jan. 29 would require First State drivers to remove accumulated ice and snow ...

Japanese automaker Toyota has teased the name of its upcoming electric three-row SUV, Highlander EV, which is set to launch globally on February 10, 2026. The shot shows the rear boot door of the SUV, ...